BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2019
View Archived Issues
Staph toxins' DARC arts: Targeting blood vessels
Read More
Alternative energy for metabolic brain disorder
Read More
H3 Biomedicine publishes preclinical pharmacokinetics and metabolism data on H3B-6545
Read More
Imbrium Therapeutics and TetraGenetics collaborate to develop novel biologic therapeutics for pain
Read More
TG Therapeutics initiates first-in-human study of its anti-CD47/CD19 bispecific antibody TG-1801
Read More
Acetylation by aspirin can attenuate autoimmunity
Read More
LY-3295668 demonstrates efficacy in RB1mut cancer models
Read More
Eribulin liposomal formulation well tolerated in patients with solid tumors
Read More
Nicotinamide N-methyltransferase inhibitor enhances aged muscle regeneration
Read More
Prion protein-binding monoclonal antibodies synthesized at New York University
Read More
Northwestern University presents beta-glucocerebrosidase activators
Read More
Bristol-Myers Squibb discovers sphingosine 1-phosphate receptor 1 agonists
Read More
New PD-1/PD-L1 interaction inhibitors patented by ChemoCentryx
Read More
Southeast University describes antibodies targeting the HPV16 E6 oncoprotein
Read More
New generation of SARDs for the treatment of advanced prostate cancer
Read More
Targeting DEFA1/DEFA3 ameliorates sepsis severity in mice
Read More
Alkermes begins ARTISTRY 2 study of subcutaneous ALKS-4230 in advanced solid tumors
Read More
Grants to support evaluation of Radspherin in colorectal cancer
Read More
Immatics Biotechnologies and Roche to test IMA-101 plus Tecentriq in cancer
Read More
FunPep gains Australian clearance for phase I/IIa study of FPP-003
Read More
MHRA clears Nuformix to begin human pharmacokinetic studies with NXP-001
Read More
Immunic initiates phase II study of IMU-838 for relapsing-remitting MS
Read More
Eidos initiates pivotal phase III study of AG-10 in ATTR-CM
Read More